Complement inhibition with the C5 blocker LFG316 in severe COVID-19

Zelek, Wioleta M., Cole, Jade, Ponsford, Mark J., Harrison, Richard A., Schroeder, Ben E., Webb, Nicholas, Jolles, Stephen, Fegan, Christopher ORCID: https://orcid.org/0000-0001-9685-0621, Morgan, Matt ORCID: https://orcid.org/0000-0003-4075-7676, Wise, Matt P. and Morgan, B. Paul ORCID: https://orcid.org/0000-0003-4075-7676 2020. Complement inhibition with the C5 blocker LFG316 in severe COVID-19. American Journal of Respiratory and Critical Care Medicine 202 (9) , pp. 1304-1308. 10.1164/rccm.202007-2778LE

PDF - Accepted Post-Print Version Available under License Creative Commons Attribution Non-commercial. Download (333kB)

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	American Thoracic Society
ISSN:	1073-449X
Date of First Compliant Deposit:	11 September 2020
Date of Acceptance:	8 September 2020
Last Modified:	16 Nov 2024 23:45
URI:	https://orca.cardiff.ac.uk/id/eprint/134757

Citation Data

Cited 27 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item